Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 15, 2024 at 4:40 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  255.93
+11.71 (4.79%)
AAPL  268.06
-2.31 (-0.85%)
AMD  258.00
+1.88 (0.73%)
BAC  53.27
-0.19 (-0.35%)
GOOG  283.34
+1.52 (0.54%)
META  643.16
-5.19 (-0.80%)
MSFT  517.00
-0.81 (-0.16%)
NVDA  209.60
+7.11 (3.51%)
ORCL  259.41
-3.20 (-1.22%)
TSLA  468.00
+11.44 (2.51%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.